Intercept Pharmaceuticals Inc ICPT

NAS: ICPT | ISIN: US45845P1084   7/11/2023
19,00 USD (+0,21%)
(+0,21%)   7/11/2023

24 oktober 2023 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTA, SPLK, ICPT, FNCB · Persbericht

24 oktober 2023 · ALERT: The M&A Class Action Firm Continues Investigating the Merger - ORTX, SRT, CHS, ICPT · Persbericht

20 oktober 2023 · Moore Kuehn Encourages ICPT, SRT, PCTI, and SP Investors to Contact Law Firm · Persbericht

19 oktober 2023 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, ICPT, FNCB · Persbericht

10 oktober 2023 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, CHS, FNCB, ICPT · Persbericht

10 oktober 2023 · SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - SATS, ICPT, AMNB, CHS · Persbericht

4 oktober 2023 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPLK, ICPT, CHS, AMTI · Persbericht

4 oktober 2023 · Moore Kuehn Encourages AMTI, SPLK, ICPT, and CHS Investors to Contact Law Firm · Persbericht

26 september 2023 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICPT, PFSW, AVTA, CATC · Persbericht

26 september 2023 · Shareholder Alert: Ademi LLP investigates whether Intercept Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Alfasigma · Persbericht

7 januari 2022 · Pomerantz Law Firm Announces the Filing of a Class Action against Intercept Pharmaceuticals, Inc. and Certain Officers - ICPT · Persbericht

10 maart 2021 · Intercept Announces Departure of Chief Financial Officer · Persbericht

19 februari 2021 · Intercept to Present at Upcoming Investor Conferences · Persbericht

27 januari 2021 · Intercept Company Statement on Analyst Note · Persbericht

4 januari 2021 · ICPT INVESTOR DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Filed Against Intercept Pharmaceuticals, Inc. · Persbericht

4 januari 2021 · DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm · Persbericht

3 januari 2021 · SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ICPT · Persbericht

Mijn selecties